(Q48632298)

13 February 2018

title

In vitro 1H-magnetic resonance spectroscopy of postmortem brains with schizophrenia. (English)

1 reference

13 February 2018

0 references

Omori M

1

1 reference

13 February 2018

Pearce J

2

1 reference

13 February 2018

Komoroski RA

3

1 reference

13 February 2018

Griffin WS

4

1 reference

13 February 2018

Mrak RE

5

1 reference

13 February 2018

Husain MM

6

1 reference

13 February 2018

Karson CN

7

1 reference

13 February 2018

language of work or name

English

0 references

publication date

1 September 1997

1 reference

13 February 2018

published in

Biological Psychiatry

1 reference

13 February 2018

volume

42

1 reference

13 February 2018

page(s)

359-366

1 reference

13 February 2018

issue

5

1 reference

13 February 2018

Magnetic resonance imaging of the brain in schizophrenia. The pathophysiologic significance of structural abnormalities

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900409-X

Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900409-X

Recent advances in the neuropathology of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900409-X

PET and MRI of the thalamus in never-medicated patients with schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900409-X

1H-magnetic resonance spectroscopy of the left temporal and frontal lobes in schizophrenia: clinical, neurodevelopmental, and cognitive correlates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900409-X

31Phosphorus magnetic resonance spectroscopy of the temporal lobes in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900409-X

Quantitative magnetic resonance imaging of the brain in late-life schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900409-X

31phosphorus magnetic resonance spectroscopy of the frontal and parietal lobes in chronic schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900409-X

Basal ganglia phosphorous metabolism in chronic schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900409-X

Midlatency auditory evoked responses in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900409-X

Diagnostic Criteria for Use in Psychiatric Research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900409-X

Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900409-X

N-acetyl-L-aspartate and other amino acid metabolites in Alzheimer's disease brain: a preliminary proton nuclear magnetic resonance study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900409-X

N-acetyl-aspartyl-glutamate: regional levels in rat brain and the effects of brain lesions as determined by a new HPLC method.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900409-X

Sensory gating and inhibitory function in late-life schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900409-X

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900409-X

N-acetyl-L-aspartic acid content of human neural tumours and bovine peripheral nervous tissues.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900409-X

Proton magnetic resonance spectroscopy (1H MRS) of the hippocampal formation in schizophrenia: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900409-X

Excitatory amino acids and neuropsychiatric disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900409-X

Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900409-X

High-resolution proton magnetic resonance spectroscopy of rabbit brain: regional metabolite levels and postmortem changes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900409-X

High-field proton magnetic resonance spectroscopy of human cerebrum obtained during surgery for epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900409-X

Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900409-X

Temporal lobe proton magnetic resonance spectroscopy of patients with first-episode psychosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900409-X

Abnormal excitatory neurotransmitter metabolism in schizophrenic brains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900409-X

10.1016/S0006-3223(96)00409-X

7 January 2021

Identifiers

DOI

1 reference

13 February 2018

PubMed ID

9276076

1 reference

13 February 2018